RESULTS GlobalEffects The global CBF of Parkinson's disease patients— 35.9 ±4.9
mL/100g/min (stagesI andII 37.5 ±4.9 mL/l00 g/min, stages III and IV 33.9 ±4.3 mL/100 …

Statistical parametric mapping was performed to investigate differences in regional cerebral
blood flow (rCBF) between patients with idiopathic Parkinson's disease (IPD), patients with …

Positron emission tomography (PET) and single-photon emission tomography (SPET)
imaging of the dopaminergic system is a powerful tool for distinguishing groups of patients …

Thirty-six patients affected by Parkinson's disease were studied using single photon
emission computed tomography (SPECT) and [99mTc]–HM-PAO as a tracer. The scanning …

Purpose The purpose of this study was to further localize cerebral perfusion abnormalities,
and to better correlate these abnormalities with the clinical severity of Parkinson's disease …

ABSTRACT BACKGROUND AND PURPOSE Computer‐based analysis of Dopamine
transporter imaging (DaTscan) can aid in image interpretation. In this study, we examined …

Positron emission tomography (PET) and single photon emission tomography (SPECT)
provide sensitive means for quantifying the loss of nigrostriatal dopaminergic fibres in …

Objective To verify if 123 I-FP-CIT, DaTSCAN® can differentiate early stages of Parkinson's
disease (PD) as well as patients with Atypical Parkinsonian syndromes (APS) from manifest …

PD patients. We then assessthe relationshipbetweenthese metabolicmeasuresandobjectiveindepende…
ratings. Methods: Twoindependentgroupsof PDpatientswere studiedwWiFDG-PEr. GroupA …

The aim of this study was to assess the ability of a single SPECT performed in the early
stage of Parkinson's disease (PD) to predict disease severity in 19 patients with early …